-
Mashup Score: 0
AUA 2021 female patients in the OLYMPUS trial, the outcomes of female patients from the OLYMPUS trial, OLYMPUS trial, patients with LG-UTUC, reverse thermal gel containing mitomycin (UGN-101 – JELMYTO® (mitomycin) upper tract urothelial carcinoma
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0AUA2021 Ramon Guiteras Lecture - Three Decades Of Bladder Cancer Treatment: Progress And Promise - 2 year(s) ago
The AUAUniversity podcast is an official podcast of the American Urological Association. More information can be found at https://auau.auanet.org
Source: SoundCloudCategories: Latest Headlines, UrologyTweet-
Dr. Eila Skinner presents "Three Decades of Bladder Cancer Treatment: Progress and Promise" - the #AUA21 Ramon Guiteras Lecture - in the @JUrology's AUA University podcast! #BladderCancer #Urology Give it a listen ➡️ https://t.co/842PyZn70k https://t.co/XrqCVhl389
-
-
Mashup Score: 8AUA2021 Journal Of Urology Lecture - The Promises And Pitfalls Of Large Database Studies - 2 year(s) ago
The AUAUniversity podcast is an official podcast of the American Urological Association. More information can be found at https://auau.auanet.org
Source: SoundCloudCategories: Latest Headlines, UrologyTweet-
In today's AUA University podcast, listen as Dr. Dave Penson @urogeek presents the #AUA21 Journal of Urology @JUrology - The Promises and Pitfalls of Large Database Studies: Lessons for the Clinician. Listen Now ➡️ https://t.co/wDJv40WYdi https://t.co/or4ttU8kQi
-
-
Mashup Score: 1AUA 2021: Long-Term Recurrence Free Survival Following UGN-101 Treatment for Low-Grade Upper Tract Urothelial Carcinoma - 2 year(s) ago
AUA 2021 kidney-sparing benefits, UGN-101 (JELMYTO), The OLYMPUS trial, long-term recurrence free survival following UGN-101 treatment for low-grade upper tract urothelial carcinoma.
Source: www.urotoday.comCategories: Latest Headlines, UrologyTweet-
Long-term recurrence-free survival following UGN-101 treatment for low-grade #UTUC. Presentation by Karim Chamie, MD, MSHS @UclaUrology. #AUA21 written coverage by @zklaassen_md @GACancerCenter > https://t.co/k0i5mhTheB @UroGenPharma @AmerUrological @drphil_urology @urojdr https://t.co/L6EVBru3ps
-
-
Mashup Score: 0AUA 2021: AUA Guideline Amendment: Non-Muscle Invasive Bladder Cancer/Muscle Invasive Bladder Cancer - 2 year(s) ago
AUA 2021 AUA guidelines, guideline update for non-muscle invasive bladder cancer, AUA guidelines muscle invasive bladder cancer, high-grade T1 disease, SWOG S0337 trial, intravesical gemcitabine versus saline immediately following TURBT.
Source: www.urotoday.comCategories: Latest Headlines, UrologyTweet-
@AmerUrological Guideline Amendment: Non-muscle invasive #BladderCancer and Muscle Invasive Bladder Cancer. Presented by @JamesJmm23 @Columbia. #AUA21 written coverage by @zklaassen_md @GACancerCenter on UroToday > https://t.co/Sf2PPn8vZR @nyphospital https://t.co/J7EIAiQK3G
-
-
Mashup Score: 3AUA 2021: Utility of Blue Light Flexible Cystoscopy for Bladder Cancer Surveillance after Intravesical Therapy - 2 year(s) ago
AUA 2021 blue light flexible cystoscopy (BLFC), Bacillus Calmette–Guérin (BCG) and intravesical chemotherapy, white light cystoscopy (WLC), early detection of recurrence in patients with NMIBC.
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet-
Utility of Blue-Light Flexible Cystoscopy for #BladderCancer Surveillance after Intravesical Therapy. Presentation by @SanamLadi @uscnorris. #AUA21 written coverage by @WallisCJD @UofT on UroToday > https://t.co/8VUelVRKFm @AmerUrological @USC_Urology https://t.co/gmzv1M1ldr
-
-
Mashup Score: 0
AUA 2021 Patients with Carcinoma in Situ (CIS), BCG-Unresponsive Non-Muscle Invasive Bladder Cancer treated with nadofaragene firadenovec, nadofaragene firadenovec has a sustained durability of response with longer follow-up in patients with high-grade BCG-unresponsive NMIBC.
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet-
The efficacy of intravesical nadofaragene firadenovec for patients with carcinoma in situ, BCG-unresponsive #NMIBC. Longer-term follow-up from the phase III trial presented by @AnneSchuckmanMD @KeckMedUSC. #AUA21 written coverage by @WallisCJD @UofT > https://t.co/3dH2NuoEq4 https://t.co/z54EfBWgTY
-
-
Mashup Score: 3AUA 2021: Anti-adenoviral Antibody Levels Predict Nadofaragene Firadenovec Response in BCG-unresponsive NMIBC- Results from a Phase 3 Trial - 2 year(s) ago
AUA 2021 the impact of anti-adenoviral antibody levels for predicting nadofaragene firadenovec response in BCG-unresponsive non-muscle invasive bladder cancer (NMIBC), Nadofaragene firadenovec, the value of anti-adenoviral antibody level as a predictor of therapeutic response in patients receiving nadofaragene firadenovec.
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet-
Anti-adenoviral antibody levels predict nadofaragene firadenovec response in BCG-unresponsive #NMIBC - results from a phase 3 trial. Presented by @APMitra @MDAndersonNews. #AUA21 written coverage by @zklaassen_md @GACancerCenter > https://t.co/LSLfumFBmG @AmerUrological https://t.co/OngUQ0OdFD
-
-
Mashup Score: 3
AUA 2021 24 month follow-up data among patients with high-grade (HG) Ta/T1 disease treated with nadofaragene firadenovec
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet-
Phase III trial of intravesical nadofaragene firadenovec in patients with high-grade, BCG-unresponsive, #NMIBC: two-year follow-up in the Ta/T1 cohort. Presented by @ylotan @UTSWUrology. #AUA21 written coverage by @WallisCJD @UofT > https://t.co/ucvlDJgJdf @AmerUrological https://t.co/EvrwgJlvJJ
-
-
Mashup Score: 4AUA 2021: Utility of Blue Light Flexible Cystoscopy for Bladder Cancer Surveillance after Intravesical Therapy - 2 year(s) ago
AUA 2021 blue light flexible cystoscopy (BLFC), Bacillus Calmette–Guérin (BCG) and intravesical chemotherapy, white light cystoscopy (WLC), early detection of recurrence in patients with NMIBC.
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet-
Utility of Blue-Light Flexible Cystoscopy for #BladderCancer Surveillance after Intravesical Therapy. Presentation by @SanamLadi @uscnorris. #AUA21 written coverage by @WallisCJD @UofT on UroToday > https://t.co/8VUelVRKFm @AmerUrological @USC_Urology https://t.co/YF1tODddYK
-
Female patients with low-grade UTUC: primary chemoablation and durability of response in a subgroup analysis from the #OLYMPUS trial. Presented by @Dr_Jen_Linehan @ProvCalifornia. #AUA21 written coverage by @tchandra_uromd @JEFFUrology > https://t.co/qIX2XqKkyN @AmerUrological https://t.co/s047UtLIhD